Company news

Alteogen Inc. news in 2026

Alteogen Inc.'s news releases, calls and decks from 2026, newest first.

View company

Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products

September 2, 2026

Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product

August 5, 2026

Alteogen Showcases ALT-B4's Potential to Transform ADC Development at World ADC Summit 2026

June 10, 2026

Decks in 2026